Beraprost sodium|496807-11-5|((Rac)-贝拉前列素钠)-陌孚医药/Medlife

您当前的位置：

Beraprost sodium (Synonyms: (Rac)-贝拉前列素钠)

目录号: PL10155 纯度: ≥99%

CAS No. :496807-11-5

商品编号	规格	价格	会员价
PL10155-5mg	5mg	¥3709.09	请登录
PL10155-10mg	10mg	¥6181.82	请登录
PL10155-25mg	25mg	¥11745.45	请登录
PL10155-50mg	50mg	询价	询价
PL10155-100mg	100mg	询价	询价
PL10155-10mM*1mLinDMSO	10mM*1mLinDMSO	¥4080.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

加入购物车在线咨询收藏产品大包装询价

中文名称	Beraprost sodium
英文名称	Beraprost sodium
英文别名	Beraprost sodium, >=98% (HPLC);rel-Sodium 4-((1S,2S,3aR,8bR)-2-hydroxy-1-((3R,E)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoate;(1S,2S,3aR,8bR)-2,3,3a,8b-Tetrahydro-2-hydroxy-1-[(E,3R)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-1H-cyclopenta[b]benzofuran-5-butanoic acid sodium salt;Sodium;4-[(1S,2S,3aR,8bR)-2-hydroxy-1-[(E,3R)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydr;Beraprost sodium
Cas No.	496807-11-5
分子式	C₂₄H₂₉NaO₅
分子量	420.47
包装储存	4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

产品详情

Beraprost sodium 是一种前列环素类似物，是一种稳定且具有口服活性的 PGI2 前药。Beraprost sodium 是有效的血管扩张剂 (vasodilator)，通过扩张肾血管，改善微循环而具有研究肺动脉高压的潜力。

生物活性

Beraprost sodium, a prostacyclin analog, is a stable and orally active prodrug of PGI2. Beraprost sodium is a potent vasodilator, has the potential for pulmonary arterial hypertension treatment through expanding renal vessels, improving microcirculation.

性状

Solid

IC50 & Target[1][2]

prodrug of PGI2; Vasodilator

体外研究(In Vitro)

Beraprost sodium (0.1, 1.0, and 10.0 μM; 24 hours) treatment leads to a significant increase in the number of tube formation, BPS plays an important role on angiogenic activity. Beraprost sodium (0.1, 1.0, and 10.0 μM; 24 hours) treatment let VE-cadherin at regions of cell–cell contact becomes more abundant and the morphology of endothelial cells tends to be normal compared with those cultured under hypoxia conditions.
has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

Beraprost sodium (oral adminstration; 0.6 mg/kg; once daily; 3 or 7 days) can mitigate the development of renal interstitial fibrosis, decrease renal oxidative stress through its potential vasodilation effect, and further prevent renal interstitial fibrosis.
has not independently confirmed the accuracy of these methods. They are for reference only.

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

ClinicalTrial

参考文献

[1]. Li S, et al. Beraprost sodium mitigates renal interstitial fibrosis through repairing renal microvessels.J Mol Med (Berl). 2019 Jun;97(6):777-791.

溶解度数据	In Vitro: DMSO : 125 mg/mL (297.29 mM; Need ultrasonic)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

相关产品

The molarity calculator equation

The dilution calculator equation